Clinical Trial Update: Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update (NCT01295567) evaluates whether dipyridamole can protect against ischemia-reperfusion injury in patients undergoing elective coron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Ischemic Heart Disease

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Cardiovascular Disease, Ischemic Heart Disease | Phase 4 | Status: COMPLETED